Regeneron Pharmaceuticals Likely To Report Lower Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Regeneron Pharmaceuticals (NASDAQ:REGN)

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) will release earnings results for its fourth quarter, before the opening bell on Friday, Jan. 30.Analysts expect the Tarrytown, New York-based company to report quarterly earnings at $10.74 per share, down from$ 12.07 per share in the year-ago period. The consensus estimate for Regeneron Pharmaceuticals' quarterly revenue is $3.79 billion, versus$ 3.79 billion a year earlier, according to data from Benzinga Pro.On Dec. 1, Regeneron Pharmaceuticals and Tessera Th ...